Evidence map›Paper›PMID 40453505›Full record

ArticleJAAD international2025

Epidemiology of cutaneous leishmaniasis in Karachi, Pakistan.

Farhan Mir Shaikh, Sandesh Raja, Azzam Ali, Adarsh Raja, Iftikhar Athar Rasool, Arfa Asad, Muhammad Sohaib Asghar

Abstract read
In one paragraph

Article in JAAD international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Farhan Mir ShaikhConsultant Dermatologist, Department of Dermatology, Institute of Skin Diseases Sindh, Karachi, Pakistan.
Sandesh RajaDepartment of Dermatology, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Azzam AliDepartment of Dermatology, Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
Adarsh RajaDepartment of Dermatology, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.
Iftikhar Athar RasoolDepartment of Dermatology, Mohtarma Shaheed Benazir Bhutto General Hospital, Quetta, Pakistan.
Arfa AsadDepartment of Dermatology, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.
Muhammad Sohaib AsgharDepartment of Internal Medicine, AdventHealth Sebring, Sebring, Florida.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Cutaneous leishmaniasis (CL), caused by Leishmania species is a prominent neglected tropical disease globally, posing substantial public health challenges. This study explores the epidemiology, clinical characteristics, geographic distribution of CL cases, and role of travel to endemic areas contributing spread of the disease to urban centers like Karachi. Methods: A retrospective study was conducted from July 2019 to February 2024, enrolling 525 patients with confirmed CL diagnoses at a leading dermatological hospital in Karachi. Demographic and clinical data, including age, gender, lesion characteristics, and travel history were collected. The chi-square test was used to compare travel history to endemic areas between individuals from Karachi and those from other regions. Results: CL predominantly affected younger age groups, with 35.5% of cases occurring in individuals aged ≤10 years. Male patients accounted for 65.1% of the cohort. Lesions were predominantly located on exposed body parts (96.3%). Most patients in this study were from Baluchistan (49.7%). In Karachi, 37% of patients reported a travel history to endemic areas, whereas only 2.17% of cases from other regions had traveled ( Conclusion: The findings underscore the need for region-specific prevention and control strategies, enhanced surveillance, and public health initiatives to mitigate the spread of CL.

Indexed as

cutaneous leishmaniasisepidemiologyKarachipublic healthvector-borne disease

Identifiers

PMID40453505
PMCPMC12123336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.